Capillary Technologies Appoints Sumit Kumar as President of Middle East, Africa & India

1 min read     Updated on 02 Apr 2026, 01:05 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Capillary Technologies has appointed Sumit Kumar as President of Middle East, Africa & India, effective April 02, 2026. Kumar brings 28 years of experience from leadership roles at Marks & Spencer, Bata, Landmark Group, Al-Futtaim, and The Clermont Group. Based in Dubai, he will lead sales strategy and client expansion across these strategic markets. The appointment strengthens Capillary's leadership team as it focuses on driving growth in the loyalty technology solutions space.

powered bylight_fuzz_icon
36660953

*this image is generated using AI for illustrative purposes only.

Capillary Technologies has announced the appointment of Sumit Kumar as President of the Middle East, Africa & India region, strengthening its leadership team to drive growth in one of its most strategic markets. The appointment was announced on April 02, 2026, through a regulatory filing with BSE and NSE.

Leadership Appointment Details

Based in Dubai, Kumar will lead Capillary's sales organization across the Middle East, Africa, and India, focusing on driving enterprise adoption of the company's award-winning loyalty platform and expanding client partnerships across key markets.

Parameter: Details
Position: President of Middle East, Africa & India
Location: Dubai
Experience: 28 years in enterprise sales and customer success
Focus Areas: Sales strategy, client base expansion, market presence

Professional Background

Kumar brings extensive experience from leadership roles at several major organizations:

  • Marks & Spencer
  • Bata
  • Landmark Group
  • Al-Futtaim
  • The Clermont Group

Throughout his career, he has consistently delivered strong revenue growth and built enduring partnerships across diverse industries. Kumar has also served as a Director and Board Member at Hoan My Medical Corporation, Vietnam's largest private healthcare group.

Strategic Responsibilities

In his new role, Kumar will be responsible for leading Capillary's sales strategy, expanding its client base, and strengthening the company's market presence. His proven track record of delivering results in highly competitive environments positions him to accelerate Capillary's growth in the region.

Management Commentary

Anant Choubey, Co-founder and COO of Capillary Technologies, commented on the appointment: "The Middle East, Africa & India continues to be a strategic region for us, and Sumit's appointment reflects our commitment to furthering our strong momentum here. His leadership and deep understanding of enterprise sales and the MEA & India market will play a crucial role in unlocking new opportunities for Capillary and helping our clients achieve transformative loyalty outcomes."

Kumar expressed his enthusiasm about the new role: "I am excited to take on this opportunity at such a pivotal time for Capillary in the Middle East, Africa & India region. As market dynamics evolve, there is a growing need for brands to rethink how they engage and retain customers. I look forward to working with our exceptional team to deliver unparalleled value to our clients and establish Capillary as the partner of choice for loyalty transformation."

Historical Stock Returns for Capillary Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+1.53%+4.69%-4.08%-18.70%-18.70%-18.70%

What specific revenue targets or market share goals has Capillary Technologies set for the MEA & India region under Kumar's leadership?

How will this leadership appointment impact Capillary's competitive positioning against other loyalty platform providers in emerging markets?

What new enterprise partnerships or industry verticals is Capillary likely to pursue given Kumar's retail and healthcare sector experience?

like17
dislike

Capillary Technologies Grants 6,563 Stock Options Under ESOP Plan 2021

2 min read     Updated on 02 Apr 2026, 04:45 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Capillary Technologies India Limited granted 6,563 stock options under ESOP Plan 2021 to eligible employees at ₹475 per option, offering a 19.85% discount to fair market value. The options vest over four years and can be exercised within 10 years from vesting or 12 years from listing date. The grant was approved on April 01, 2026, and complies with SEBI regulations for employee stock option schemes.

powered bylight_fuzz_icon
36630955

*this image is generated using AI for illustrative purposes only.

Capillary technologies has announced the granting of 6,563 stock options to eligible employees under its Employee Stock Option Scheme 2021. The grant was approved through a circular resolution by the company's Nomination and Remuneration Committee on April 01, 2026, in compliance with SEBI regulations and listing requirements.

Grant Details and Pricing

The stock options were granted with specific terms designed to incentivize employee retention and performance. Each option provides the right to apply for one equity share with a face value of ₹2.

Parameter Details
Total Options Granted 6,563 stock options
Face Value per Share ₹2
Exercise Price ₹475 per option
Discount to Market Value 19.85%
Grant Date April 01, 2026

The exercise price of ₹475 per option represents a significant discount of 19.85% to the fair market value, calculated as the volume weighted average price of shares for 90 days immediately preceding the working day prior to the grant date on the stock exchange with the highest trading volume.

Vesting and Exercise Terms

The granted options follow a structured vesting schedule designed to ensure employee retention and alignment with company objectives. The vesting period spans four years, subject to fulfillment of conditions specified in individual grant letters.

Vesting Parameter Details
Vesting Period Four years
Exercise Window 10 years from vesting date or 12 years from listing date
Resignation Clause Vested options exercisable within 1 year from last working day
Additional Conditions As mentioned in individual grant letters

Employees have flexibility in exercising their vested options, with the exercise window extending to either 10 years from the date of vesting or 12 years from the company's listing date, whichever occurs later. In cases of resignation, all vested options remain exercisable for one year from the employee's last working day.

Regulatory Compliance

The stock option grant complies with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company has fulfilled all disclosure requirements under Regulation 30 of the SEBI Listing Regulations, ensuring transparency for stakeholders.

The announcement was signed by Gireddy Bhargavi Reddy, Company Secretary and Compliance Officer, and the information has been made available on the company's investor relations website. This ESOP grant represents part of Capillary Technologies' ongoing employee incentive strategy to attract and retain talent in the competitive technology sector.

Historical Stock Returns for Capillary Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+1.53%+4.69%-4.08%-18.70%-18.70%-18.70%

How will this ESOP grant impact Capillary Technologies' talent retention rates compared to competitors in the technology sector?

What percentage of the company's total equity will be diluted once all 6,563 stock options are exercised?

Could this employee incentive strategy signal Capillary Technologies' preparation for a major expansion or acquisition in the coming years?

like17
dislike

More News on Capillary Technologies

1 Year Returns:-18.70%